Lexaria Bioscience - Warrants (11/01/2026) Current Cash

As of the most recent data (May 2026), LEXXW shows a current cash of $3.5M. That compares with $4.6M in the prior-year period — down 24.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LEXXW's current cash is now $3.5M (was $4.6M) — a 24.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Lexaria Bioscience - Warrants (11/01/2026) is outperforming or lagging.

Tracking LEXXW's current cash over time shows whether Lexaria Bioscience - Warrants (11/01/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $3.5M That compares with $4.6M in the prior-year period — down 24.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Lexaria Bioscience - Warrants (11/01/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $3.5M) with ownership activity and broader fundamentals.

Lexaria Bioscience - Warrants (11/01/2026)'s current cash is $3.5M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.